Evaluation of effect of consumption kafir probiotic on saliva count of candida albicans in chemotherapy patients
Phase 2
- Conditions
- Oral candidiasis.Candidiasis
- Registration Number
- IRCT201506181760N41
- Lead Sponsor
- Vice Chancellor for Research and Technology, Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Breast Cancer Patients with Cancer of the colon or candidate for chemotherapy; Patients aged twenty to sixty years with the same chemotherapy regimen
Exclusion criteria:
Patients with a history of chemotherapy and radiation therapy; Patients with atrophic tongue; Anemia; With mucocutaneous disease; The use of partial or full dentures; With a history of oral diseases; People with underlying medical conditions (eg, diabetes, hypertension, etc.); Pregnant women; Smokers; The use of broad-spectrum antibiotics and anti-fungal drugs
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of Candida albicans in normal flora. Timepoint: Before receiving chemotherapy treatment and at the end of last sampling of the patients taking probiotics. Method of measurement: Laboratory.
- Secondary Outcome Measures
Name Time Method